These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival postradiotherapy in oral squamous cell carcinoma patient. Sun Y; Yang J; Cai H; Liu J; Liu Y; Luo J; Zhou H J Oral Pathol Med; 2022 Aug; 51(7):611-619. PubMed ID: 35708285 [TBL] [Abstract][Full Text] [Related]
29. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis. Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760 [TBL] [Abstract][Full Text] [Related]
30. Identification of potential CpG sites for oral squamous cell carcinoma diagnosis via integrated analysis of DNA methylation and gene expression. Chen L; Wang D World J Surg Oncol; 2021 Jan; 19(1):16. PubMed ID: 33468155 [TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India. Reddy VR; Annamalai T; Narayanan V; Ramanathan A Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838 [TBL] [Abstract][Full Text] [Related]
32. The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma. Zhou C; Li J; Li Q; Liu H; Ye D; Wu Z; Shen Z; Deng H J Clin Lab Anal; 2019 Jun; 33(5):e22873. PubMed ID: 30843252 [TBL] [Abstract][Full Text] [Related]
33. Hypermethylated PAX1 and ZNF582 genes in the tissue sample are associated with aggressive progression of oral squamous cell carcinoma. Sun R; Juan YC; Su YF; Zhang WB; Yu Y; Yang HY; Yu GY; Peng X J Oral Pathol Med; 2020 Sep; 49(8):751-760. PubMed ID: 32428271 [TBL] [Abstract][Full Text] [Related]
34. Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis. Uchida K; Veeramachaneni R; Huey B; Bhattacharya A; Schmidt BL; Albertson DG BMC Cancer; 2014 May; 14():353. PubMed ID: 24886209 [TBL] [Abstract][Full Text] [Related]
35. Aberrant promoter methylation of T-cadherin in sera is associated with a poor prognosis in oral squamous cell carcinoma. Wang Q; Chen Y; Chen Y; Jiang J; Song X; Zhang L; He Q; Ye B; Wu L; Wu R; Lai Q; Wang D; Zhao Y Neoplasma; 2021 May; 68(3):528-534. PubMed ID: 33567853 [TBL] [Abstract][Full Text] [Related]
36. Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma. Khor GH; Froemming GR; Zain RB; Abraham TM; Lin TK Asian Pac J Cancer Prev; 2016; 17(1):219-23. PubMed ID: 26838213 [TBL] [Abstract][Full Text] [Related]
37. Promoter methylation of MGMT in oral carcinoma: A population-based study and meta-analysis. Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K Arch Oral Biol; 2017 Aug; 80():197-208. PubMed ID: 28458179 [TBL] [Abstract][Full Text] [Related]
38. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma]. Yue ZW; Liu JZ Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924 [No Abstract] [Full Text] [Related]
39. Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population. Goel H; Mathur R; Syeda S; Shrivastava A; Jha AK Asian Pac J Cancer Prev; 2021 Mar; 22(3):977-982. PubMed ID: 33773564 [TBL] [Abstract][Full Text] [Related]
40. Reduced ribosomal RNA expression and unchanged ribosomal DNA promoter methylation in oral squamous cell carcinoma. Ha S; Zhou H; Gautam M; Song Y; Wang C Mol Genet Genomic Med; 2019 Jul; 7(7):e00783. PubMed ID: 31169368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]